WIA
GBT

Wealthstreet Investment Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Wealthstreet Investment Advisors’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,500
Closed -$469K – 349
2021
Q1 		$469K Buy
11,500
+3,200
+39% +$147K 0.05% 253
2020
Q4 		$359K Buy
+8,300
New +$409K 0.04% 278

Other funds holding GBT

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Wealthstreet Investment Advisors's GBT Position: Q2 2021 in Review

Wealthstreet Investment Advisors sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2021, closing a stake of 11,500 shares — an estimated $469K sold.

Wealthstreet Investment Advisors first reported a position in GBT in Q4 2020 and held it in 2 quarters. The position peaked at $469K in Q1 2021. 192 funds tracked by Wall St. Rank hold GBT as of Q2 2021.

  • Wealthstreet Investment Advisors reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Wealthstreet Investment Advisors sold 11,500 Global Blood Therapeutics, Inc. shares in Q2 2021, an estimated $469K.
  • Wealthstreet Investment Advisors first reported a position in Global Blood Therapeutics, Inc. in Q4 2020 and held it in 2 quarters.
  • Wealthstreet Investment Advisors's Global Blood Therapeutics, Inc. position peaked at $469K in Q1 2021.
  • 192 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2021.

Based on Wealthstreet Investment Advisors's 13F filing for Q2 2021, filed 2 Aug 2021.